Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
3.350
+0.250 (8.06%)
At close: Mar 9, 2026, 4:00 PM EDT
3.390
+0.040 (1.19%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Galectin Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 216 | 81 | 103 | 67 | 123 | 128 | |
| Market Cap Growth | 134.00% | -21.14% | 52.89% | -45.33% | -3.92% | -21.41% | |
| Enterprise Value | 331 | 163 | 147 | 84 | 109 | 98 | |
| Last Close Price | 3.35 | 1.29 | 1.66 | 1.13 | 2.07 | 2.24 | |
| PB Ratio | - | -0.79 | -1.70 | -2.09 | 46.96 | 5.29 | |
| P/TBV Ratio | - | - | - | - | 335.62 | 5.83 | |
| Debt / Equity Ratio | -1.02 | -1.03 | -1.19 | -1.24 | 11.11 | 0.00 | |
| Net Debt / Equity Ratio | -0.93 | -0.88 | -0.77 | -0.66 | -4.05 | -1.12 | |
| Quick Ratio | 0.08 | 0.43 | 1.64 | 1.43 | 4.39 | 5.03 | |
| Current Ratio | 0.09 | 0.49 | 1.77 | 1.58 | 4.63 | 5.46 | |
| Return on Equity (ROE) | - | - | - | - | -227.74% | -67.25% | |
| Return on Assets (ROA) | -87.09% | -116.08% | -96.17% | -75.96% | -52.81% | -37.54% | |
| Return on Capital Employed (ROCE) | 23.60% | 236.90% | -304.00% | -463.60% | -92.00% | -96.90% | |
| Earnings Yield | -17.34% | -58.11% | -40.00% | -57.74% | -24.85% | -18.35% | |
| Buyback Yield / Dilution | -2.12% | -3.57% | -1.29% | -1.48% | -2.63% | -9.17% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.